The report provides a detailed analysis essential for establishing a Tranylcypromine production plant. It encompasses all critical aspects necessary for Tranylcypromine production, including the cost of Tranylcypromine production, Tranylcypromine plant cost, Tranylcypromine production costs, and the overall Tranylcypromine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Tranylcypromine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Tranylcypromine is a nonhydrazine antidepressant that boosts brain chemicals like serotonin and norepinephrine to improve mood. It is utilised in major depressive disorder, such as atypical or treatment-resistant forms, unresponsive to other antidepressants. It is reserved for second- or third-line therapy because of strict tyramine-free diet requirements and risks of hypertensive crisis from interactions with sympathomimetics, serotonergic drugs or decongestants.
It also treats social anxiety disorder, panic disorder, OCD and solid tumours in combination therapies, like with all-trans retinoic acid. It also aids negative symptoms in schizophrenia adjunctively. Its common side effects include dry mouth, dizziness, headache, insomnia, constipation, drowsiness, blurred vision, shakiness, etc.
The market for Tranylcypromine is driven by growing cases of depression around the globe. The mental health awareness and destigmatisation boost demand for treatment-resistant cases. The rise in ageing populations and healthcare infrastructure expansion in developing markets fuels its growth. The factors like competition from generic because of expired patents and multiple API suppliers, along with regulations like dietary restrictions affects industrial Tranylcypromine procurement. Also, the limiting prescriptions to refractory depression, and supply chain instability from shortages impacts its sourcing. The requirement for quality compliance (GMP and DMFs), along with usage in oncology, further influences affordability and access.
Raw Material for Tranylcypromine Production
According to the Tranylcypromine production plant project report, the key raw materials used in the production of Tranylcypromine include Styrene, ethyl diazoacetate, thionyl chloride, and sodium azide.
Production Process of Tranylcypromine
The extensive Tranylcypromine production cost report consists of the following major industrial production process:
- By Alkaline Hydrolysis: The production process of Tranylcypromine starts with the synthesis of the ethyl ester of 2-phenylcyclopropanecarboxylic acid by reacting styrene with ethyl diazoacetate. This ester goes through alkaline hydrolysis to form 2-phenylcyclopropanecarboxylic acid, from which the trans-isomer is isolated. The trans-acid then reacts with thionyl chloride to produce the acid chloride, which is treated with sodium azide to form the acid azide. The acid azide undergoes Curtius rearrangement to yield Tranylcypromine as the final product.
Tranylcypromine appears as white to light beige crystalline powder or chunks with a faint cinnamaldehyde-like odour. It has a molecular formula of C9H11N and a molecular weight of 133.19 g/mol for the free base. It has a melting point between 79-80 degree Celsius for the base and 162-169 degree Celsius for the salt. It shows moderate water solubility around 40 mg/mL at 25 degree Celsius. It shows higher solubility in DMSO but is limited in ethanol or methanol. It has moderate lipophilicity, reflected by a LogP value of 1.34-1.58. It requires storage as a hygroscopic solid at 2-8 degree Celsius. It works as an irreversible monoamine oxidase that features a trans-(1R)-2-phenylcyclopropan-1-amine structure, and maintains a pKa near 9.62 at its strongest basic site.